Galaxy Surfactants Q1 FY27 Share Price & Earnings Call Analysis

₹2,172.80+0.14% today
Market cap
₹7,704 Cr
P/E
21.20
ROE
10.89%
PEG
-2.11
Price to sales
1.34
Debt to equity
0.09
52W high / low
₹2,609 / ₹1,515
Sales growth (5Y)
13.52%
EBITDA margin
10.44%
Net profit margin
5.30%
Promoter holding
70.91%
Sales (last year)
₹5,752 Cr

Galaxy Surfactants Ltd was Incorporated in 1986. It’s a leading manufacturer of Performance Surfactants and Specialty Care products with over 205 product grades. These products are used in consumer-centric Home and Personal care products like hair care, oral care, skin care, cosmetics, soap, shampoo, lotion, detergent, cleaning products, etc. Preferred suppliers to leading MNC’s, Regional and Local FMCG brands.[1] The company is India’s Largest Manufacturer of Oleo chemical-based Surfactants and Specialty Care Products for Home Care and Personal Care Industries [2]

Guidance scorecard · Q1 FY27 call

What Galaxy Surfactants Ltd's management guided
and where it ranks in Chemicals & Petrochemicals

#70of 71 in
Chemicals & Petrochemicals

RevenueQ1 FY27 call

0–10%
  • Volume growth guidance maintained at 6% to 8% for full year FY26-27.
  • Confident of sustaining 6% to 7% average volume growth beyond Q3-Q4 despite AMET market challenges.
  • India region expected to continue strong volume growth, driven by rural demand and premiumization.
  • Specialty ingredients and performance surfactants businesses both targeted for growth—no shift away from either.
  • New specialty products pipeline expected to contribute over 5% of total revenue and margins by 2030.
  • Inorganic growth pursued cautiously with acquisitions under evaluation, aiming for strategic fit and profitability accretion.

2 more points from Galaxy Surfactants Ltd's call on revenue

Create a free account to keep reading this call

Full Q1 FY27 analysis

MarginsQ1 FY27 call

Flat

See what Galaxy Surfactants Ltd said on margins — free account, 30 seconds.

Full Q1 FY27 analysis

CapexQ1 FY27 call

Planned
  • Galaxy Surfactants plans a capex of about INR 150 crores for the current year, similar to the previous year.
  • Some capex has already been front-loaded and commissioned, with the remainder to be commissioned this year.
  • Capex is aimed at capacity expansions, including debottlenecking exercises, and preparing for anticipated business growth.
  • There is a focus on growing both performance and specialty chemical segments.
  • Inorganic growth via M&A is actively being evaluated; managment is seeking the right fit aligned with strategy and profitability.
  • No planned acquisitions in the AMET market currently; any inorganic moves will be accretive and strategic.

2 more points from Galaxy Surfactants Ltd's call on capex

Create a free account to keep reading this call

Full Q1 FY27 analysis

FundraisingQ1 FY27 call

See what Galaxy Surfactants Ltd said on fundraising — free account, 30 seconds.

Full Q1 FY27 analysis

Order bookQ1 FY27 call

Rising
  • It is mentioned that in the U.S. market, customer approvals and project approvals have started falling in place, indicating an improving order pipeline.
  • The management highlighted good customer acceptance and project momentum, especially for new products like TRI-K and Everbond in the U.S. market.
  • The momentum in demand remains healthy across key markets including India, U.S., and APAC.

2 more points from Galaxy Surfactants Ltd's call on the order book

Create a free account to keep reading this call

Full Q1 FY27 analysis

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. 2
  2. Strong growth
    1
  3. Strong growth
    3

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 0–2%₹263 Cr3.4
240%+Flat₹4,375 Cr83.7
340%+Flat₹3,259 Cr4.0
440%+Flat₹145 Cr15.9
520–40%Up 2%+₹1.81L Cr90.9
620–40%Up 2%+₹48,366 Cr78.3

Sign up free to see every company in the sector ranking and track Galaxy Surfactants Ltd.

Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals ranking

Financials of Galaxy Surfactants Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Galaxy Surfactants Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +9809429839409299741,0631,0421,1451,2781,3261,3291,315
Expenses +8458198588288278509359361,0181,1541,2161,2101,193
Operating Profit135123125112102124128106127124110119122
OPM %14%13%13%12%11%13%12%10%11%10%8%9%9%
Other Income +7236245948116-70
Interest6656544567798
Depreciation23242525262728282829303133
Profit before tax11396988894991047710099797380
Tax %20%22%21%19%18%19%19%16%24%20%16%19%22%
Net Profit +91757771788085657679665962
EPS in Rs25.5321.2021.8420.1321.8622.4823.8918.2221.4022.4218.7516.6317.61

Financials of Galaxy Surfactants Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +1,8701,7992,1582,4322,7612,5952,7823,6844,4623,7924,2215,248
Expenses +1,6811,5631,8862,1442,4082,2262,3343,2843,8943,3303,7374,773
Operating Profit190236271288353369449401568462484475
OPM %10%13%13%12%13%14%16%11%13%12%11%9%
Other Income +26101056111310352610
Interest343427313024131322221931
Depreciation454547495162747183100110123
Profit before tax112163207219277289372329473375380332
Tax %40%37%29%28%31%20%19%20%19%20%20%19%
Net Profit +67103148158191230302263381301305267
EPS in Rs19.0328.9741.6444.5753.8764.9985.2274.12107.4685.0386.0075.41
Dividend Payout %21%31%14%16%15%22%21%24%20%26%5%0%

Financials of Galaxy Surfactants Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital353535353535353535353535
Reserves3424125396838411,0321,2661,5391,8472,1442,3272,709
Borrowings +451412393348298396289421327187210235
Other Liabilities +231250315385389348458602518539877894
Total Liabilities1,0601,1091,2831,4521,5631,8122,0492,5972,7282,9063,4503,874
Fixed Assets +4594364564475197487127609239731,0301,174
CWIP75110258366124205139158262181
Investments0000064300198299474
Other Assets +5946238179809629921,1701,6301,6651,5761,8592,045
Total Assets1,0601,1091,2831,4521,5631,8122,0492,5972,7282,9063,4503,874

Financials of Galaxy Surfactants Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +411701111452833163655573518421333
Cash from Investing Activity +-26-59-43-54-166-149-166-82-141-341-290-378
Cash from Financing Activity +-17-110-57-90-119-144-16559-264-189-157-51
Net Cash Flow-20111-22334-18168-11-27-96
Free Cash Flow151166889115174258-150429362205198
CFO/OP49%98%62%71%101%104%97%16%118%129%101%85%

Financials of Galaxy Surfactants Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days435159635662626350575952
Inventory Days6872797568729110378829574
Days Payable505963715960807552668161
Cash Conversion Cycle616475676573729176737365
Working Capital Days42731394143506355645280
ROCE %23%26%25%28%24%25%19%24%17%16%13%

Guidance history

How Galaxy Surfactants Ltd's guidance has moved, call by call

CallRevenueMarginsCapexFundraisingOrder book
Q1 FY27 call →0–10%FlatPlanned—Rising
Q4 FY26 call →0–10%FlatNone planned——
Q3 FY26 call →0–10%FlatPlanned——
Q2 FY26 call →0–10%FlatPlanned——

What management guided on each call, newest first. Not investment advice, and not a forecast of returns.

34out of 100

Momentum score · price trend

34 out of 100 — Cooling

Over the past year its share price has done worse than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months−4.3%56%
Last 6 months+17.0%72%
Last 3 months+11.4%80%

The price is 36.2% below its all-time high of ₹3,404.45 (14 Oct 2021). Stocks more than 20% below their peak have their score halved, so 67 became 34.

How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Galaxy Surfactants Ltd: 0.4 × 56 + 0.4 × 72 + 0.2 × 80 = 67, halved to 34 because the price is more than 20% below its all-time high.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 29 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Others in Chemicals & Petrochemicals this season

  • POCL Enterprises Ltd (Q1 FY27)

    466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto

  • Deepak Nitrite Ltd (Q2 FY27)

    Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese

  • Privi Speciality Chemicals Ltd (Q2 FY27)

    19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks

  • NOCIL Ltd (Q2 FY27)

    427 crores . Key investor presentation takeaways from NOCIL Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.